BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12791684)

  • 1. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter.
    Marks J; Saifudeen Z; Dipp S; El-Dahr SS
    J Biol Chem; 2003 Sep; 278(36):34158-66. PubMed ID: 12791684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
    Saifudeen Z; Du H; Dipp S; El-Dahr SS
    J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
    Saifudeen Z; Dipp S; Fan H; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of parathyroid hormone-related peptide (PTHrP) gene transcription: cell- and tissue-specific promoter utilization mediated by multiple positive and negative cis-acting DNA elements.
    Campos RV; Wang C; Drucker DJ
    Mol Endocrinol; 1992 Oct; 6(10):1642-52. PubMed ID: 1280327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
    Li B; Lee MY
    J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.
    Ku WC; Chiu SK; Chen YJ; Huang HH; Wu WG; Chen YJ
    Mol Cell Proteomics; 2009 Sep; 8(9):2034-50. PubMed ID: 19505873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.
    van Bodegom D; Roessingh W; Pridjian A; El Dahr SS
    Biochim Biophys Acta; 2010 Jul; 1799(7):502-9. PubMed ID: 20388565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.
    Lee MH; Kim YJ; Yoon WJ; Kim JI; Kim BG; Hwang YS; Wozney JM; Chi XZ; Bae SC; Choi KY; Cho JY; Choi JY; Ryoo HM
    J Biol Chem; 2005 Oct; 280(42):35579-87. PubMed ID: 16115867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic nuclear factor 3 and nuclear factor 1 regulate 5-aminolevulinate synthase gene expression and are involved in insulin repression.
    Scassa ME; Guberman AS; Ceruti JM; Cánepa ET
    J Biol Chem; 2004 Jul; 279(27):28082-92. PubMed ID: 15123725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter.
    Ikuyama S; Shimura H; Hoeffler JP; Kohn LD
    Mol Endocrinol; 1992 Oct; 6(10):1701-15. PubMed ID: 1333054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor p53 regulates its own transcription.
    Deffie A; Wu H; Reinke V; Lozano G
    Mol Cell Biol; 1993 Jun; 13(6):3415-23. PubMed ID: 7684498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the rat bradykinin B2 receptor gene: identification of a silencer element.
    Baptista HA; Avellar MC; Araujo RC; Pesquero JL; Schanstra JP; Bascands JL; Esteve JP; Paiva AC; Bader M; Pesquero JB
    Mol Pharmacol; 2002 Dec; 62(6):1344-55. PubMed ID: 12435802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter.
    Thornborrow EC; Manfredi JJ
    J Biol Chem; 2001 May; 276(19):15598-608. PubMed ID: 11278953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UV responsive elements in the human mimecan promoter: a functional characterization.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.
    Pastorcic M; Das HK
    J Biol Chem; 2000 Nov; 275(45):34938-45. PubMed ID: 10942770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.